Vincent Descamps
Vincent Descamps is an expert in Dermatology at Hôpital Bichat-Claude-Bernard (France). Vincent Descamps has authored 442 publications, the most recent in 2026, and is an investigator in 10 clinical trials. SLR score: 1,221 (community average: 125). How the SLR is computed.
LeadR Profile
Dermatology
Subspecialties: Pharmacy - Immunology - Infectiology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1991 - 2026
Number : 442
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| The spectrum of eosinophilic cellulitis (Wells' syndrome): new insights based on 114 cases. PMID 42551694 — hypersensitivity, adrenal cortex hormones, cellulitis, eosinophils, therapeutics | J Allergy Clin Immunol Pract | 2026 | 0 |
| Management and predictors of ICU admission in DRESS: A multicentre retrospective cohort study. PMID 42141852 — sexually transmitted diseases, mortality, pharmaceutical preparations, drug hypersensitivity syndrome, cohort studies, hospital mortality, skin diseases, critical illness, intensive care units, eosinophilia | J Eur Acad Dermatol Venereol | 2026 | 0 |
| Serological diagnosis of chronic skin granulomas caused by wild-type or vaccine-derived rubella virus in patients with inherited HLA class I deficiency. PMID 41531537 — skin, granuloma, vaccines, rubella, rubella virus, viruses, diagnosis | J Hum Immun | 2025 | 0 |
| Real-world outcomes of immune checkpoint inhibitors in people with HIV and skin cancer: a multicentre study. PMID 41396687 — skin, cells, safety, melanoma, neoplasms, sarcoma, immune checkpoint inhibitors, hiv, therapeutics, skin neoplasms | Oncologist | 2025 | 0 |
| Minocycline-induced DRESS: could dosage in relation to body fat mass be a contributing factor? PMID 41079722 — drug-related side effects and adverse reactions, minocycline, risk factors | Front Pharmacol | 2025 | 0 |
Clinical Studies 10
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 3
LeadR Networks
Main global connection map